April 29th 2025
The company’s exhibitions will be focused in the areas of its pipeline, proprietary capsid engineering, and manufacturing.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Nexcella Begins Production of CAR-T Cell Therapy Engineering Batches at US Manufacturing Site
May 31st 2023The start of production of US engineering batches of NXC-201, a CAR-T cell therapy candidate in early clinical development, is the first step in transferring Nexcella’s existing manufacturing process to the United States.
Investigating the Pharmaceutical Ingredients Industry with Myrna Wilson (DCAT Week 2023)
May 26th 2023Myrna Wilson, director, Global Marketing, Strategic Growth and Technical Sales, Pharmaceutical Ingredients, Univar Solutions, discusses the state of the biopharma supply chain, movements in the patent industry, and more.
TriLink BioTechnologies to Expand Manufacturing Capabilities
May 24th 2023The new CGMP facility is expected to contribute to the development of mRNA therapeutics, with a building designed for the CGMP manufacture of mRNA-based in-vivo gene editing, gene-edited cell therapies, protein replacement therapies, cancer vaccines, and infectious disease vaccines.